Irish Minister for Jobs, Enterprise and Innovation, Richard Bruton TD, has announced that ArisGlobal, a leading provider of software for the Life Sciences sector is to expand its European operations in Dublin with the creation of 50 new high quality jobs. The investment is supported by the Irish Government through IDA Ireland.
ArisGlobal (www.arisglobal.com) is a key provider of innovative software solutions for pharmacovigilance and safety, regulatory affairs, clinical research and medical information. Hundreds of life science companies rely on ArisGlobal’s advanced solutions for maintaining regulatory compliance, workflow automation, improving operational efficiency and easily sharing information around the globe.
The company employs over 700 people, across sites in India, the US, the UK, Europe and Japan. It is now actively recruiting for its planned office in Dublin.?
Making the announcement, Minister for Jobs, Enterprise and Innovation, Richard Bruton TD said:?’A key aim of the Government’s Action Plan for Jobs is to attract and grow investment from major companies in the Health and Life Sciences sector.
This announcement by ArisGlobal that it is going to expand its operations in Ireland sends a clear message that Ireland offers a strong business environment in which companies can expand and grow their global presence which will result in the creation of valuable job opportunities for this economy.
We in Government are determined to implement policies to continue the strong flow of investment and jobs in this area’.?
Welcoming the announcement, Mr. Deepak Abbhi, President and CEO of ArisGlobal said, ‘The expansion of the European operations of ArisGlobal in Ireland will enable us to take the lead in providing cloud based solutions for pharmaceutical research and development.
In addition this expansion will strengthen sales and marketing and services delivery for the company’s European market as part of our global expansion.
Ireland was chosen as the location for this operation due to the availability of a highly-skilled and flexible workforce and a competitive, pro-business environment. I would like to thank the Irish Government and IDA Ireland for their support in this important initiative and look forward to the continued growth of ArisGlobal in Ireland.’?
Commenting on the announcement, Barry O’Leary, CEO of IDA Ireland said, ‘The decision by ArisGlobal, to locate its European operations in Dublin, marks an important win for Ireland in developing the pharmaceutical regulation and compliance industry, in which ArisGlobal plays a pivotal role. ArisGlobal is a strategic brand name in the health care sector and its presence in Ireland has the potential to act as a magnet for the company’s impressive client list in the health care sector; a sector is a key focus for IDA Ireland.’’
